As Managing Director, Ben provides clients insights and expertise across healthcare strategy, policy, advocacy and communications. He also serves as the Executive Director of the Global CEO Initiative on Alzheimer’s Disease which connects the patient advocacy and business communities to reduce barriers to Alzheimer’s diagnosis, treatment and care.
Previously, Ben led Field Reimbursement for Johnson & Johnson’s Innovative Medicine franchises and was the Chief of Staff Johnson & Johnson’s Vice Chairman prior to his appointment as CEO. Ben also worked within J&J’s Government Affairs & Policy, Global Public Health and Global Commercial Strategy teams. He holds a PhD in Molecular Biology and a master’s in public policy from Princeton University.